Suppr超能文献

子宫内膜癌中雌激素受体(ER)、孕激素受体(PR)和HER-2/neu受体的表达及其与肿瘤组织学类型、分级和分期的关系。

Expression of Estrogen Receptors (ER), Progesterone Receptors (PR) and HER-2/neu receptors in Endometrial Carcinoma and their associations with histological types, grades and stages of the tumor.

作者信息

Waqar Samina, Khan Saleem Ahmad, Sarfraz Tariq, Waqar Saba

机构信息

Dr. Samina Waqar, M.Phil. Department of Histopathology, Army Medical College/ Military Hospital, Rawalpindi, Pakistan.

Dr. Saleem Ahmad Khan, PhD. Department of Hematology, Army Medical College/ Military Hospital, Rawalpindi, Pakistan.

出版信息

Pak J Med Sci. 2018 Mar-Apr;34(2):266-271. doi: 10.12669/pjms.342.13637.

Abstract

OBJECTIVE

To study and detect immunohistochemical expression of Estrogen Receptors, Progestrone Receptors and HER-2/neu Receptors in Endometrial Carcinoma (EC) and to find their associations with histological types, grades and stages of the tumor.

METHODS

A cross sectional study of one year duration from January 2016 to January 2017 was conducted at Histopathology department of Army Medical College, Rawalpindi. A non-probability purposive sampling technique was used to include 56 cases of EC. The specimens were tested for ER, PR and HER-2/neu expression using immunohistochemical analysis. Data was analyzed in SPSS and the significance of association of expression of the receptors with histological types, grades and stages of the tumor was assessed.

RESULTS

Significant association of Her-2/neu overexpression with histological types and grades of EC was seen, whereas the association of ER and PR expression with histological types, grades and stage of EC was statistically insignificant.

CONCLUSION

It is suggested that EC showing over expression of HER2/neu with immunohistochemistry may be treated with anti HER-2/neu treatment with better chances of survival and decreased post-treatment morbidity.

摘要

目的

研究并检测子宫内膜癌(EC)中雌激素受体、孕激素受体及HER-2/neu受体的免疫组化表达情况,探讨其与肿瘤组织学类型、分级及分期的相关性。

方法

2016年1月至2017年1月,在拉瓦尔品第陆军医学院组织病理学科室开展了一项为期一年的横断面研究。采用非概率立意抽样技术纳入56例子宫内膜癌病例。运用免疫组化分析检测标本中的雌激素受体(ER)、孕激素受体(PR)及HER-2/neu表达情况。数据在SPSS软件中进行分析,评估受体表达与肿瘤组织学类型、分级及分期之间相关性的显著性。

结果

观察到HER-2/neu过表达与子宫内膜癌的组织学类型及分级存在显著相关性,而雌激素受体(ER)和孕激素受体(PR)表达与子宫内膜癌的组织学类型、分级及分期之间的相关性无统计学意义。

结论

提示免疫组化显示HER2/neu过表达的子宫内膜癌患者,采用抗HER-2/neu治疗可能具有更好的生存机会,并降低治疗后发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85bc/5954362/0a308bf30295/PJMS-34-266-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验